Heart disease is the leading cause of death among US women over the age of 65, resulting in more deaths than all forms of cancer combined. Women are less likely to survive heart attacks than are men, possibly because symptoms in women may differ and may be less recognizable. In addition, women consistently tend to have worse clinical outcomes in percutaneous coronary interventions than do men. For these reasons, an issue on percutaneous interventions in women is timely.
1. Cover - p. 1 2. Contributors - p. 2 3. Contents - p. 3 4. Forthcoming Issues - p. 4 5. Coronary Artery Disease in Women: Shyly Bold? - p. 5 6. An Approach to Asymptomatic and Atypically or Typically Symptomatic Women with Cardiac Disease - p. 6 7. Revascularization Strategies in Women with Stable Cardiovascular Disease: What do the Trials Reveal? - p. 11 8. Interventional Management of ACS in Women: STEMI and NSTEMI - p. 17 9. The Generations of Drug-Eluting Stents and Outcomes in Women - p. 24 10. PCI Outcomes in High-Risk Groups (Diabetes Mellitus, Smoker, Chronic Kidney Disease and the Elderly) - p. 34 11. Vascular Complications in Women and the Radial Approach - p. 41 12. Is Stenting an Appropriate Therapy in Women Presenting with Acute Coronary Syndrome? A Pathologist’s Perspective - p. 45 13. Does Gender have an Influence on Platelet Function and the Efficacy of Oral Antiplatelet Therapy? - p. 50 14. Cardiogenic Shock in Women - p. 56 15. Percutaneous Valve Therapy: Choosing the Appropriate Patients and Outcomes - p. 65 16. Future Perspectives on Percutaneous Coronary Interventions in Women - p. 70 17. Index - p. 75
Heart disease is the leading cause of death among US women over the age of 65, resulting in more deaths than all forms of cancer combined. Women are less likely to survive heart attacks than are men, possibly because symptoms in women may differ and may be less recognizable. In addition, women consistently tend to have worse clinical outcomes in percutaneous coronary interventions than do men. For these reasons, an issue on percutaneous interventions in women is timely.
1. Cover - p. 1 2. Contributors - p. 2 3. Contents - p. 3 4. Forthcoming Issues - p. 4 5. Coronary Artery Disease in Women: Shyly Bold? - p. 5 6. An Approach to Asymptomatic and Atypically or Typically Symptomatic Women with Cardiac Disease - p. 6 7. Revascularization Strategies in Women with Stable Cardiovascular Disease: What do the Trials Reveal? - p. 11 8. Interventional Management of ACS in Women: STEMI and NSTEMI - p. 17 9. The Generations of Drug-Eluting Stents and Outcomes in Women - p. 24 10. PCI Outcomes in High-Risk Groups (Diabetes Mellitus, Smoker, Chronic Kidney Disease and the Elderly) - p. 34 11. Vascular Complications in Women and the Radial Approach - p. 41 12. Is Stenting an Appropriate Therapy in Women Presenting with Acute Coronary Syndrome? A Pathologist’s Perspective - p. 45 13. Does Gender have an Influence on Platelet Function and the Efficacy of Oral Antiplatelet Therapy? - p. 50 14. Cardiogenic Shock in Women - p. 56 15. Percutaneous Valve Therapy: Choosing the Appropriate Patients and Outcomes - p. 65 16. Future Perspectives on Percutaneous Coronary Interventions in Women - p. 70 17. Index - p. 75
